Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition

NCT05673369 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Endocrine, Nutritional and Metabolic Diseases

Interventions

DRUG: CKD-387
DRUG: D484

Sponsor

Chong Kun Dang Pharmaceutical